Generating mutant rats using the Sleeping Beauty transposon system
Introduction
The laboratory rat (Rattus norvegicus) remains the major animal model system inside the pharmaceutical and biomedical research industries largely because “size does matter”. Importantly, rat models tend to be disease based, generating more information about the actual disease of interest, rather than just being an animal model. Unfortunately, geneticists have long preferred the mouse model because of its smaller size, which simplified housing requirements, and the availability of many coat color and mutants exhibiting Mendelian patterns of inheritance. In addition, the availability of mouse embryonic stem (ES) cells for gene-specific characterization and knockout studies has made this model indispensable. Although the availability of rat transgenic technologies have allowed advances in the field of gene-specific analysis, the lack of rat ES cells has hampered any further progress in this field. Germline-competent rat ES cells has been reported recently and may revolutionize this field [1], [2]. However, the robustness for large-scale generation of mutant rats remains to be tested. Chemical mutagenesis has been widely used in the rat [3], however, a large portion of induced mutations are point-mutation and thus not null alleles in most cases, and moreover, identifying the causative gene seems to be a challenging task by this method.
Sleeping Beauty (SB) transposon system is a novel genetic tool developed around a decade ago [4]. It consists of two components: The SB transposon, which is excised and reinserted into other locations of the genome, and the SB transposase catalyzes this reaction. Since most of the vertebrate transposase genes are inactivated during evolution, the SB transposase was reconstructed by extensive manipulation of inactive transposase copies from the fish genome. The SB transposon contains inverted repeat/direct repeat (IR/DR) elements at either ends (Fig. 1a), which are essential sequence for the recognition and mobilization by the SB transposase. Recently, others and we have demonstrated the effectiveness of SB for large-scale germline mutagenesis in mice [5], [6], [7]. Analysis of the SB transposition sites revealed preference of transposition on the donor-site chromosome, which varied between 60% to 80% amongst SB transposon-transgenic lines, whereas remaining 20–40% was distributed in various locations of the genome [5], [6]. Many of the transpositions on the donor-site chromosome were clustered within 3–4 Mb from the donor site [5], [6]. Others and we further applied the SB transposon system in rats, and succeeded in rapid generation of mutants [8], [9].
In the present paper, we describe a protocol for the generation and analysis of the mutant rats based on the SB transposon vectors developed in our laboratory [8]. It should be noted that various transposon systems have been developed recently and some of them have been shown to be active in mammalian cells, such as Tol2 [10], PiggyBac [11], Minos [12], and Frog Prince [13]. Although their application for insertional mutagenesis in rat remains to be addressed, it is conceivable that some of them will have different characteristics compared with SB, such as different patterns of transposition distribution [14] and different rates of transposition events. Therefore, it is highly likely that these DNA-type transposable elements will complement SB as a mutagenesis tool. Most of the protocol described in this paper can be easily modified and applicable to other transposon systems by simple modification.
Section snippets
Overview (Fig. 1)
Vector structures and general mutagenesis scheme are shown in Fig. 1. The initial part is to generate two transgenic rat lines, one containing a donor concatemer of transposon gene-trap vectors and the other containing a source of transposase (Fig. 1a). The transposon gene-trap vector concatemer source consists of a promoter-trap component and a polyA-trap component. The promoter-trap component consists of human BCL2 intron 2/exon3 splice acceptor (SA) [15], encephalomyocarditis virus internal
Concluding remarks
Despite its importance as an animal model for human diseases, generation of mutant rat resource lags far behind the mutant resources currently available for the mouse model. This is due to the lack an efficient high throughput mutagenesis platform. The simplicity of the transposon-based mutagenesis approach described in the current paper will help open and expand an area of research previously unavailable for the rat animal model and hopefully establish a mutant rat resource that will greatly
References (23)
- et al.
Cell
(2008) - et al.
Cell
(2008) - et al.
Cell
(1997) - et al.
Cell
(2005) - et al.
Nat. Biotechnol.
(2003) - et al.
Mol. Cell. Biol.
(2003) - et al.
Nat. Methods
(2005) - et al.
Genetics
(2003) - et al.
Nat. Methods
(2007) - et al.
Mamm. Genome
(2007)
Genetics
Cited by (17)
Neoplastic disease
2019, The Laboratory RatGene targeting in rats using transcription activator-like effector nucleases
2014, MethodsCitation Excerpt :Over the two decades, several technologies have been developed to modify the rat genome. These technologies include pronuclear microinjection [6–7], lentiviral transgenesis [8–10], N-ethyl-N-nitroso urea mutagenesis [11–12], transposon mutagenesis [13–15], embryonic stem cells [16–18], zinc-finger nuclease (ZFNs) [19–23] transcription activator-like effector (TALE) nucleases [24] and recently CRISPR-Cas9 system [25–26]. TALE nucleases are hybrid molecules consist on modular repeats, each recognizing one base pair, fused of the catalytic domain of the FokI endonuclease.
PK-15cells transfected with porcine CD163 by PiggyBac transposon system are susceptible to porcine reproductive and respiratory syndrome virus
2013, Journal of Virological MethodsCitation Excerpt :The Sleeping Beauty (SB) is the first DNA transposon system that has been described to work in mammalian cells and is also the most widely used transposon system for mammalian transgenesis and mutagenesis (Takeda et al., 2007; Wang et al., 2008). For example, SB has been used to identify new cancer genes (Collier et al., 2005; Dupuy et al., 2006) and generate transgene animals (Kitada et al., 2009). However, SB transposition application is limited by its relatively low transposition efficiency and its nonspecific integration (Wu et al., 2006; Yant et al., 2005).
Retake the Center Stage - New Development of Rat Genetics
2012, Journal of Genetics and GenomicsCitation Excerpt :Transposon-based genetic manipulations in rodent model organisms were led by the discovery and development of the SB transposon system (Takeda et al., 2007; Mátés et al., 2009). The SB transposon was engineered from several fish genomes over 10 years ago, and first applied to generate random saturation mutagenesis in mice, then utilized to develop insertional mutations in rats (Kitada et al., 2009). The SB transposon belongs to the Tc1/mariner superfamily of DNA transposons.
PiRNAs, transposon silencing, and germline genome integrity
2011, Mutation Research - Fundamental and Molecular Mechanisms of MutagenesisCitation Excerpt :Mobilization of this element has been shown to result in somatic and embryonic cancers when induced [153–155]. The SB TE has also been utilized to generate transgenic rats [156] as well as in gene therapy using animal models [157]. Modifications of TEs to carry vital genes and to control their insertion will be of great interest for future gene therapy trials.
Knockout and knock-in mouse models to study purinergic signaling
2020, Methods in Molecular Biology